Symbols / CDXS Stock $2.50 -1.57% Codexis, Inc.
CDXS (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-11-22 | reit | Cantor Fitzgerald | Overweight → Overweight | $11 |
| 2024-11-15 | reit | Cantor Fitzgerald | Overweight → Overweight | $11 |
| 2024-11-04 | reit | Benchmark | — → Hold | — |
| 2024-09-20 | reit | Cantor Fitzgerald | Overweight → Overweight | $11 |
| 2024-08-29 | reit | Cantor Fitzgerald | Overweight → Overweight | $11 |
| 2024-08-19 | down | Benchmark | Buy → Hold | — |
| 2024-08-09 | reit | Cantor Fitzgerald | Overweight → Overweight | $11 |
| 2024-05-30 | init | Cantor Fitzgerald | — → Overweight | $11 |
| 2024-05-03 | reit | Benchmark | Buy → Buy | $9 |
| 2024-02-29 | up | Benchmark | Hold → Buy | $9 |
| 2023-11-07 | down | Benchmark | Buy → Hold | — |
| 2023-11-06 | main | Piper Sandler | Overweight → Overweight | $10 |
| 2023-09-01 | reit | Benchmark | Buy → Buy | $9 |
| 2023-08-14 | main | Stifel | Buy → Buy | $5 |
| 2023-07-21 | reit | Stephens & Co. | Overweight → Overweight | $6 |
| 2023-05-09 | main | Benchmark | — → Buy | $9 |
| 2023-05-09 | down | HC Wainwright & Co. | Buy → Neutral | — |
| 2023-04-17 | main | Piper Sandler | — → Overweight | $14 |
| 2023-02-27 | main | HC Wainwright & Co. | — → Buy | $9 |
| 2023-01-19 | main | Piper Sandler | — → Overweight | $23 |
- Codexis says it has cash through 2027 as siRNA plans advance - Stock Titan hu, 07 May 2026 20
- Earnings Release: Here's Why Analysts Cut Their Codexis, Inc. (NASDAQ:CDXS) Price Target To US$6.58 - Yahoo Finance Mon, 11 May 2026 11
- US$6.58: That's What Analysts Think Codexis, Inc. (NASDAQ:CDXS) Is Worth After Its Latest Results - simplywall.st Mon, 11 May 2026 12
- Codexis, Inc. (CDXS) Stock Price Today & Analysis - Gotrade Fri, 10 Apr 2026 18
- Number of shareholders of Codexis, Inc. – NASDAQ:CDXS - TradingView Mon, 11 May 2026 12
- Codexis (CDXS) Reports Strong Q1 Revenue and Upcoming Data Prese - GuruFocus Fri, 08 May 2026 12
- Codexis stock rises after Q4 beat, outlook (CDXS:NASDAQ) - Seeking Alpha hu, 12 Mar 2026 07
- Codexis (NASDAQ: CDXS) Q1 2026 revenue hits $15.2M as net loss shrinks - Stock Titan hu, 07 May 2026 20
- Codexis (CDXS) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance hu, 07 May 2026 23
- Codexis (CDXS) Confident in Financial Stability Through 2027 - GuruFocus Fri, 08 May 2026 10
- Revenue surges as Codexis (CDXS) narrows quarterly loss and manages debt load - Stock Titan hu, 07 May 2026 20
- Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance Wed, 11 Mar 2026 07
- Down 30% in 4 Weeks, Here's Why You Should You Buy the Dip in Codexis (CDXS) - Yahoo Finance ue, 11 Nov 2025 08
- Codexis heads to Boston with new RNA manufacturing data and panel - Stock Titan Wed, 29 Apr 2026 07
- Opaleye (NASDAQ: CDXS) holds 7.47% of Codexis, 6.785M shares - Stock Titan ue, 05 May 2026 20
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
70.39
+18.61%
|
59.34
-15.39%
|
70.14
-49.39%
|
138.59
|
| Operating Revenue |
|
70.39
+18.61%
|
59.34
-15.39%
|
70.14
-49.39%
|
138.59
|
| Cost Of Revenue |
|
9.34
-42.67%
|
16.29
+27.16%
|
12.81
-66.32%
|
38.03
|
| Reconciled Cost Of Revenue |
|
9.34
-42.67%
|
16.29
+27.16%
|
12.81
-66.32%
|
38.03
|
| Gross Profit |
|
61.05
+41.79%
|
43.06
-24.90%
|
57.33
-42.98%
|
100.56
|
| Operating Expense |
|
99.38
-2.00%
|
101.41
-9.56%
|
112.14
-15.22%
|
132.27
|
| Research And Development |
|
52.31
+13.06%
|
46.26
-21.44%
|
58.88
-26.48%
|
80.10
|
| Selling General And Administration |
|
47.07
-14.64%
|
55.15
+3.56%
|
53.25
+2.07%
|
52.17
|
| Total Expenses |
|
108.72
-7.63%
|
117.70
-5.80%
|
124.94
-26.63%
|
170.30
|
| Operating Income |
|
-38.33
+34.31%
|
-58.35
-6.48%
|
-54.80
-72.80%
|
-31.71
|
| Total Operating Income As Reported |
|
-41.74
+28.67%
|
-58.52
+14.03%
|
-68.07
-95.15%
|
-34.88
|
| EBITDA |
|
-33.87
+32.14%
|
-49.90
+14.52%
|
-58.38
-121.87%
|
-26.31
|
| Normalized EBITDA |
|
-30.46
+38.76%
|
-49.74
-10.26%
|
-45.11
-94.91%
|
-23.14
|
| Reconciled Depreciation |
|
5.25
+6.11%
|
4.95
-10.37%
|
5.52
+2.15%
|
5.40
|
| EBIT |
|
-39.11
+28.69%
|
-54.85
+14.16%
|
-63.90
-101.48%
|
-31.71
|
| Total Unusual Items |
|
-3.41
-1964.85%
|
-0.17
+98.76%
|
-13.27
-318.95%
|
-3.17
|
| Total Unusual Items Excluding Goodwill |
|
-3.41
-1964.85%
|
-0.17
+98.76%
|
-13.27
-318.95%
|
-3.17
|
| Special Income Charges |
|
-3.41
-1964.85%
|
-0.17
+98.76%
|
-13.27
-318.95%
|
-3.17
|
| Impairment Of Capital Assets |
|
0.00
-100.00%
|
0.17
-98.35%
|
9.98
|
0.00
|
| Restructuring And Mergern Acquisition |
|
3.41
|
0.00
-100.00%
|
3.28
+3.69%
|
3.17
|
| Net Income |
|
-43.97
+32.63%
|
-65.28
+14.38%
|
-76.24
-126.96%
|
-33.59
|
| Pretax Income |
|
-43.93
+32.67%
|
-65.24
+14.35%
|
-76.17
-128.63%
|
-33.32
|
| Net Non Operating Interest Income Expense |
|
-2.19
+67.46%
|
-6.72
+17.02%
|
-8.10
-662.25%
|
1.44
|
| Interest Expense Non Operating |
|
4.81
-53.69%
|
10.39
-15.33%
|
12.27
|
—
|
| Net Interest Income |
|
-2.19
+67.46%
|
-6.72
+17.02%
|
-8.10
-662.25%
|
1.44
|
| Interest Expense |
|
4.81
-53.69%
|
10.39
-15.33%
|
12.27
|
—
|
| Interest Income Non Operating |
|
2.62
-28.47%
|
3.67
-12.03%
|
4.17
+189.52%
|
1.44
|
| Interest Income |
|
2.62
-28.47%
|
3.67
-12.03%
|
4.17
+189.52%
|
1.44
|
| Other Income Expense |
|
-3.41
-1964.85%
|
-0.17
+98.76%
|
-13.27
-336.02%
|
-3.04
|
| Other Non Operating Income Expenses |
|
—
|
-10.39
+15.33%
|
-12.27
-9998.39%
|
0.12
|
| Tax Provision |
|
0.05
+38.24%
|
0.03
-50.72%
|
0.07
-75.00%
|
0.28
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.72
-1964.85%
|
-0.03
+98.76%
|
-2.79
-318.95%
|
-0.67
|
| Net Income Including Noncontrolling Interests |
|
-43.97
+32.63%
|
-65.28
+14.38%
|
-76.24
-126.96%
|
-33.59
|
| Net Income From Continuing Operation Net Minority Interest |
|
-43.97
+32.63%
|
-65.28
+14.38%
|
-76.24
-126.96%
|
-33.59
|
| Net Income From Continuing And Discontinued Operation |
|
-43.97
+32.63%
|
-65.28
+14.38%
|
-76.24
-126.96%
|
-33.59
|
| Net Income Continuous Operations |
|
-43.97
+32.63%
|
-65.28
+14.38%
|
-76.24
-126.96%
|
-33.59
|
| Normalized Income |
|
-41.28
+36.63%
|
-65.15
+0.93%
|
-65.76
-111.51%
|
-31.09
|
| Net Income Common Stockholders |
|
-43.97
+32.63%
|
-65.28
+14.38%
|
-76.24
-126.96%
|
-33.59
|
| Diluted EPS |
|
—
|
-0.89
+20.54%
|
-1.12
-119.61%
|
-0.51
|
| Basic EPS |
|
—
|
-0.89
+20.54%
|
-1.12
-119.61%
|
-0.51
|
| Basic Average Shares |
|
—
|
73.41
+7.75%
|
68.13
+4.27%
|
65.34
|
| Diluted Average Shares |
|
—
|
73.41
+7.75%
|
68.13
+4.27%
|
65.34
|
| Diluted NI Availto Com Stockholders |
|
-43.97
+32.63%
|
-65.28
+14.38%
|
-76.24
-126.96%
|
-33.59
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
147.80
-0.81%
|
149.01
+9.12%
|
136.56
-45.46%
|
250.39
|
| Current Assets |
|
96.82
-1.98%
|
98.77
+5.68%
|
93.47
-42.62%
|
162.89
|
| Cash Cash Equivalents And Short Term Investments |
|
78.21
+6.47%
|
73.46
+12.81%
|
65.12
-42.87%
|
113.98
|
| Cash And Cash Equivalents |
|
50.79
+163.67%
|
19.26
-70.42%
|
65.12
-42.87%
|
113.98
|
| Cash Equivalents |
|
20.14
+26.06%
|
15.98
-71.65%
|
56.37
-27.08%
|
77.31
|
| Cash Financial |
|
30.65
+833.25%
|
3.28
-62.43%
|
8.74
-76.16%
|
36.67
|
| Other Short Term Investments |
|
27.42
-49.41%
|
54.19
|
0.00
|
—
|
| Receivables |
|
10.69
-43.41%
|
18.88
-5.24%
|
19.93
-51.24%
|
40.87
|
| Accounts Receivable |
|
8.76
-26.54%
|
11.92
+18.77%
|
10.04
-68.54%
|
31.90
|
| Gross Accounts Receivable |
|
8.80
-27.16%
|
12.08
+19.61%
|
10.10
-68.50%
|
32.07
|
| Allowance For Doubtful Accounts Receivable |
|
-0.04
+73.46%
|
-0.16
-149.23%
|
-0.07
+60.12%
|
-0.16
|
| Receivables Adjustments Allowances |
|
-0.04
+73.46%
|
-0.16
-149.23%
|
-0.07
+60.12%
|
-0.16
|
| Other Receivables |
|
1.97
-72.33%
|
7.13
-28.43%
|
9.96
+9.03%
|
9.13
|
| Inventory |
|
1.82
+1.00%
|
1.80
-33.00%
|
2.69
+32.33%
|
2.03
|
| Raw Materials |
|
—
|
0.00
-100.00%
|
0.11
+0.00%
|
0.11
|
| Work In Process |
|
0.00
-100.00%
|
0.03
+314.29%
|
0.01
-92.31%
|
0.09
|
| Finished Goods |
|
1.82
+2.66%
|
1.77
-31.13%
|
2.57
+40.44%
|
1.83
|
| Prepaid Assets |
|
—
|
—
|
—
|
5.49
|
| Restricted Cash |
|
0.48
-4.97%
|
0.50
-3.08%
|
0.52
-0.38%
|
0.52
|
| Other Current Assets |
|
5.63
+36.29%
|
4.13
-20.89%
|
5.22
-4.90%
|
5.49
|
| Total Non Current Assets |
|
50.98
+1.48%
|
50.24
+16.58%
|
43.09
-50.75%
|
87.50
|
| Net PPE |
|
43.52
+1.46%
|
42.90
+49.86%
|
28.62
-53.74%
|
61.88
|
| Gross PPE |
|
88.77
+5.89%
|
83.83
+23.40%
|
67.94
-33.20%
|
101.70
|
| Accumulated Depreciation |
|
-45.24
-10.52%
|
-40.94
-4.13%
|
-39.31
+1.28%
|
-39.82
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
3.69
+2.96%
|
3.58
-11.18%
|
4.03
-7.98%
|
4.38
|
| Construction In Progress |
|
0.41
-88.23%
|
3.44
+110.33%
|
1.64
-5.92%
|
1.74
|
| Other Properties |
|
69.44
+7.42%
|
64.65
+28.39%
|
50.35
-36.22%
|
78.94
|
| Leases |
|
15.23
+25.25%
|
12.16
+2.07%
|
11.91
-28.38%
|
16.63
|
| Goodwill And Other Intangible Assets |
|
2.46
+0.00%
|
2.46
+0.00%
|
2.46
-24.00%
|
3.24
|
| Goodwill |
|
2.46
+0.00%
|
2.46
+0.00%
|
2.46
-24.00%
|
3.24
|
| Investments And Advances |
|
2.50
-10.72%
|
2.80
-71.15%
|
9.70
-52.71%
|
20.51
|
| Other Non Current Assets |
|
2.50
+19.89%
|
2.08
-9.84%
|
2.31
+23.36%
|
1.87
|
| Total Liabilities Net Minority Interest |
|
97.27
+18.50%
|
82.08
+64.35%
|
49.95
-52.70%
|
105.60
|
| Current Liabilities |
|
25.32
+7.06%
|
23.65
-34.00%
|
35.83
-26.98%
|
49.07
|
| Payables And Accrued Expenses |
|
4.32
-52.30%
|
9.06
-15.18%
|
10.68
-42.34%
|
18.52
|
| Payables |
|
1.55
-45.24%
|
2.84
-52.28%
|
5.95
+83.21%
|
3.25
|
| Accounts Payable |
|
1.55
-45.24%
|
2.84
-52.28%
|
5.95
+83.21%
|
3.25
|
| Current Accrued Expenses |
|
2.77
-55.52%
|
6.22
+31.43%
|
4.74
-69.01%
|
15.28
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
11.04
-3.23%
|
11.41
+1.46%
|
11.25
-1.81%
|
11.45
|
| Current Debt And Capital Lease Obligation |
|
2.94
+4.14%
|
2.83
-25.23%
|
3.78
-29.46%
|
5.36
|
| Current Capital Lease Obligation |
|
2.94
+4.14%
|
2.83
-25.23%
|
3.78
-29.46%
|
5.36
|
| Current Deferred Liabilities |
|
7.01
+1902.57%
|
0.35
-96.54%
|
10.12
-26.27%
|
13.73
|
| Current Deferred Revenue |
|
7.01
+1902.57%
|
0.35
-96.54%
|
10.12
-26.27%
|
13.73
|
| Total Non Current Liabilities Net Minority Interest |
|
71.95
+23.13%
|
58.44
+313.97%
|
14.12
-75.03%
|
56.53
|
| Long Term Debt And Capital Lease Obligation |
|
70.26
+23.12%
|
57.07
+366.13%
|
12.24
-68.02%
|
38.28
|
| Long Term Debt |
|
40.10
+38.75%
|
28.91
|
—
|
—
|
| Long Term Capital Lease Obligation |
|
30.16
+7.09%
|
28.16
+130.03%
|
12.24
-68.02%
|
38.28
|
| Non Current Deferred Liabilities |
|
0.36
+260.00%
|
0.10
-84.38%
|
0.64
-96.21%
|
16.88
|
| Non Current Deferred Revenue |
|
0.36
+260.00%
|
0.10
-84.38%
|
0.64
-96.21%
|
16.88
|
| Other Non Current Liabilities |
|
1.33
+4.65%
|
1.27
+2.84%
|
1.23
-10.07%
|
1.37
|
| Stockholders Equity |
|
50.53
-24.50%
|
66.93
-22.73%
|
86.61
-40.18%
|
144.80
|
| Common Stock Equity |
|
50.53
-24.50%
|
66.93
-22.73%
|
86.61
-40.18%
|
144.80
|
| Capital Stock |
|
0.01
+12.50%
|
0.01
+14.29%
|
0.01
+16.67%
|
0.01
|
| Common Stock |
|
0.01
+12.50%
|
0.01
+14.29%
|
0.01
+16.67%
|
0.01
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
90.48
+10.54%
|
81.85
+17.09%
|
69.91
+6.22%
|
65.81
|
| Ordinary Shares Number |
|
90.48
+10.54%
|
81.85
+17.09%
|
69.91
+6.22%
|
65.81
|
| Additional Paid In Capital |
|
657.29
+4.39%
|
629.67
+7.80%
|
584.14
+3.19%
|
566.08
|
| Retained Earnings |
|
-606.78
-7.81%
|
-562.81
-13.12%
|
-497.53
-18.10%
|
-421.29
|
| Gains Losses Not Affecting Retained Earnings |
|
0.01
-84.62%
|
0.05
|
0.00
|
—
|
| Other Equity Adjustments |
|
0.01
-84.62%
|
0.05
|
—
|
—
|
| Total Equity Gross Minority Interest |
|
50.53
-24.50%
|
66.93
-22.73%
|
86.61
-40.18%
|
144.80
|
| Total Capitalization |
|
90.63
-5.42%
|
95.83
+10.64%
|
86.61
-40.18%
|
144.80
|
| Working Capital |
|
71.50
-4.83%
|
75.12
+30.34%
|
57.64
-49.37%
|
113.83
|
| Invested Capital |
|
90.63
-5.42%
|
95.83
+10.64%
|
86.61
-40.18%
|
144.80
|
| Total Debt |
|
73.21
+22.23%
|
59.90
+273.78%
|
16.02
-63.28%
|
43.64
|
| Net Debt |
|
—
|
9.64
|
—
|
—
|
| Capital Lease Obligations |
|
33.10
+6.82%
|
30.99
+93.40%
|
16.02
-63.28%
|
43.64
|
| Net Tangible Assets |
|
48.07
-25.44%
|
64.46
-23.40%
|
84.15
-40.55%
|
141.56
|
| Tangible Book Value |
|
48.07
-25.44%
|
64.46
-23.40%
|
84.15
-40.55%
|
141.56
|
| Available For Sale Securities |
|
2.50
-10.72%
|
2.80
-71.15%
|
9.70
-52.71%
|
20.51
|
| Investmentin Financial Assets |
|
2.50
-10.72%
|
2.80
-71.15%
|
9.70
-52.71%
|
20.51
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-19.38
+60.79%
|
-49.41
+6.13%
|
-52.64
-566.48%
|
11.28
|
| Cash Flow From Continuing Operating Activities |
|
-19.38
+60.79%
|
-49.41
+6.13%
|
-52.64
-566.48%
|
11.28
|
| Net Income From Continuing Operations |
|
-43.97
+32.63%
|
-65.28
+14.38%
|
-76.24
-126.96%
|
-33.59
|
| Depreciation Amortization Depletion |
|
5.25
+6.11%
|
4.95
-10.37%
|
5.52
+2.15%
|
5.40
|
| Depreciation |
|
—
|
—
|
9.92
-3.20%
|
10.25
|
| Depreciation And Amortization |
|
5.25
+6.11%
|
4.95
-10.37%
|
5.52
+2.15%
|
5.40
|
| Other Non Cash Items |
|
1.31
+48.81%
|
0.88
+21925.00%
|
0.00
+113.79%
|
-0.03
|
| Stock Based Compensation |
|
9.62
-26.46%
|
13.09
+31.25%
|
9.97
-31.38%
|
14.53
|
| Provisionand Write Offof Assets |
|
-0.11
-216.49%
|
0.10
+249.23%
|
-0.07
-1725.00%
|
0.00
|
| Asset Impairment Charge |
|
3.34
-67.38%
|
10.25
-61.47%
|
26.60
+448.65%
|
4.85
|
| Operating Gains Losses |
|
—
|
—
|
-0.21
+82.89%
|
-1.25
|
| Gain Loss On Investment Securities |
|
—
|
—
|
-0.21
+82.89%
|
-1.25
|
| Unrealized Gain Loss On Investment Securities |
|
—
|
0.00
|
0.00
+100.00%
|
-0.21
|
| Change In Working Capital |
|
6.42
+153.41%
|
-12.02
+34.04%
|
-18.22
-184.45%
|
21.57
|
| Change In Inventory |
|
-0.02
-102.14%
|
0.89
+235.06%
|
-0.66
+24.51%
|
-0.87
|
| Change In Prepaid Assets |
|
-1.69
-289.70%
|
0.89
+203.24%
|
-0.86
-577.90%
|
0.18
|
| Change In Payables And Accrued Expense |
|
-1.29
+49.90%
|
-2.57
-212.24%
|
2.29
+1004.83%
|
0.21
|
| Change In Payable |
|
-1.29
+49.90%
|
-2.57
-212.24%
|
2.29
+1004.83%
|
0.21
|
| Change In Account Payable |
|
-1.29
+49.90%
|
-2.57
-212.24%
|
2.29
+1004.83%
|
0.21
|
| Change In Other Working Capital |
|
4.07
+148.88%
|
-8.33
+75.42%
|
-33.89
-211.11%
|
30.50
|
| Change In Other Current Assets |
|
8.51
+579.47%
|
1.25
-93.82%
|
20.25
+727.81%
|
-3.23
|
| Change In Other Current Liabilities |
|
-3.16
+23.85%
|
-4.15
+22.28%
|
-5.34
-2.26%
|
-5.22
|
| Investing Cash Flow |
|
23.50
+141.25%
|
-56.98
-1072.91%
|
-4.86
+64.22%
|
-13.58
|
| Cash Flow From Continuing Investing Activities |
|
23.50
+141.25%
|
-56.98
-1072.91%
|
-4.86
+64.22%
|
-13.58
|
| Net PPE Purchase And Sale |
|
-4.47
-5.88%
|
-4.22
-15.03%
|
-3.67
+55.70%
|
-8.28
|
| Purchase Of PPE |
|
-4.47
-3.86%
|
-4.30
+2.56%
|
-4.42
+46.82%
|
-8.31
|
| Sale Of PPE |
|
0.01
-94.25%
|
0.09
-88.42%
|
0.75
+2489.66%
|
0.03
|
| Capital Expenditure |
|
-4.47
-3.86%
|
-4.30
+2.56%
|
-4.42
+46.82%
|
-8.31
|
| Net Investment Purchase And Sale |
|
27.97
+153.01%
|
-52.76
-4330.06%
|
-1.19
+77.53%
|
-5.30
|
| Purchase Of Investment |
|
-57.16
+36.66%
|
-90.23
-7476.41%
|
-1.19
+77.53%
|
-5.30
|
| Sale Of Investment |
|
85.13
+127.17%
|
37.47
|
0.00
|
0.00
|
| Financing Cash Flow |
|
27.93
-53.85%
|
60.52
+641.06%
|
8.17
+1520.35%
|
-0.57
|
| Cash Flow From Continuing Financing Activities |
|
27.93
-53.85%
|
60.52
+641.06%
|
8.17
+1520.35%
|
-0.57
|
| Net Issuance Payments Of Debt |
|
9.90
-66.47%
|
29.52
|
0.00
|
0.00
|
| Issuance Of Debt |
|
9.90
-66.47%
|
29.52
|
0.00
|
0.00
|
| Repayment Of Debt |
|
—
|
—
|
—
|
0.00
|
| Long Term Debt Issuance |
|
9.90
-66.47%
|
29.52
|
0.00
|
0.00
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
0.00
|
| Net Long Term Debt Issuance |
|
9.90
-66.47%
|
29.52
|
0.00
|
0.00
|
| Net Common Stock Issuance |
|
17.27
-44.87%
|
31.32
+261.99%
|
8.65
|
0.00
|
| Proceeds From Stock Option Exercised |
|
1.60
-21.03%
|
2.03
+381.04%
|
0.42
-55.81%
|
0.95
|
| Net Other Financing Charges |
|
-0.84
+64.27%
|
-2.35
-158.88%
|
-0.91
+40.72%
|
-1.53
|
| Changes In Cash |
|
32.05
+169.88%
|
-45.87
+7.02%
|
-49.33
-1619.38%
|
-2.87
|
| Beginning Cash Position |
|
20.83
-68.77%
|
66.70
-42.52%
|
116.03
-2.41%
|
118.89
|
| End Cash Position |
|
52.88
+153.89%
|
20.83
-68.77%
|
66.70
-42.52%
|
116.03
|
| Free Cash Flow |
|
-23.85
+55.60%
|
-53.72
+5.86%
|
-57.06
-2016.56%
|
2.98
|
| Interest Paid Supplemental Data |
|
3.15
+22.72%
|
2.57
+5731.82%
|
0.04
+29.41%
|
0.03
|
| Income Tax Paid Supplemental Data |
|
0.00
-100.00%
|
0.02
-91.24%
|
0.19
+94.00%
|
0.10
|
| Amortization Of Securities |
|
-1.23
+10.58%
|
-1.38
|
0.00
|
—
|
| Common Stock Issuance |
|
17.27
-44.87%
|
31.32
+261.99%
|
8.65
|
0.00
|
| Issuance Of Capital Stock |
|
17.27
-44.87%
|
31.32
+261.99%
|
8.65
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-Q2026-05-07 View
- 8-K2026-05-07 View
- 8-K2026-04-14 View
- 10-K2026-03-11 View
- 8-K2026-03-11 View
- 42026-02-25 View
- 42026-02-25 View
- 42026-02-25 View
- 42026-02-09 View
- 42026-02-09 View
- 42026-02-09 View
- 42026-01-08 View
- 42025-12-01 View
- 42025-11-25 View
- 42025-11-17 View
- 42025-11-14 View
- 42025-11-13 View
- 42025-11-12 View
- 42025-11-12 View
- 10-Q2025-11-06 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|